{"schema_version":"secwatch.filing_event.v1","accession":"0001847903-24-000041","form_type":"8-K","ticker":"CNTA","cik":"0001847903","company_name":"Centessa Pharmaceuticals plc","filed_at":"2024-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.986270+00:00","generated_at":"2026-06-06T04:58:26.187824+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Centessa files 8-K referencing SerpinPC clinical update but no data in exhibit","bullets":["Exhibit 99.1 only contains a title slide and standard disclaimers; no numerical results provided.","Presentation is posted on company website but not fully reproduced in the filing.","SerpinPC is an investigational serpin for haemophilia A/B with or without inhibitors.","No financial or guidance changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001847903-24-000041","json":"https://secwatch.observer/filing/0001847903-24-000041.json","markdown":"https://secwatch.observer/filing/0001847903-24-000041.md","text":"https://secwatch.observer/filing/0001847903-24-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847903/000184790324000041/0001847903-24-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847903/000184790324000041/cnta-20240209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:58:26.187824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}